Bellefleur has been acquired by Domidep
Belgian nursing home Bellefleur has been sold to Domidep, one of France’s largest private nursing home operators.
Headquartered in Aubange, Belgium, Bellefleur owns and operates a state-of-the-art nursing home in the Luxembourg province. After the nursing home’s refurbishment and extension in 2022, Bellefleur operates 91 accredited beds, with a total capacity for 99 beds. Through its strategic location, a limited competitive landscape in the region and efficient management, Bellefleur has been able to achieve an occupancy rate of around 100% for long-term stays since 2022.
Founded in 1989, Domidep is a leading player in the healthcare sector, operating mainly medicalized nursing homes. On the strength of its roots and experience in France, with almost 120 establishments at the end of 2022 accommodating 7,700 residents, Domidep is now also expanding internationally. The company is already present in Germany and Belgium, with over 35 establishments for almost 2,900 residents.
Oaklins’ team in Belgium acted as the exclusive M&A sell-side advisor to Bellefleur in this transaction.
Sprechen Sie mit dem Deal-Team
Thomas Roelens
Oaklins KBC Securities
Relevante Transaktionen
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Weitere InformationenEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Weitere InformationenOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Weitere Informationen